Bactiguard AB 

€1.3200
0
-€0.01-0.75% 06:01 Today

Statistics

Day High
1.32
Day Low
1.32
52W High
3.31
52W Low
1.145
Volume
-
Avg. Volume
-
Mkt Cap
40.98M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

22OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.3
-0.08
0.14
0.35
Expected EPS
-0.197396856
Actual EPS
N/A

Financials

-3.49%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
19.72MRevenue
-688,293.84Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Bactiguard Holding AB (publ), a Swedish-based global medical technology company, specializes in developing and supplying innovative solutions designed to prevent infections. Its primary objective is to mitigate healthcare-associated infections (HAIs) and reduce the global dependency on antibiotics. The core of Bactiguard's product line, known as Bactiguard Infection Protection (BIP), encompasses a range of coated medical devices. This includes various urinary catheters, such as the BIP Foley Catheter and the temperature-sensing BIP Foley TempSensor, all engineered to inhibit microbial adhesion and prevent urinary tract infections. Similarly, the BIP Central Venous Catheter and BIP Endotracheal Tube (with the BIP Endotracheal Tube Evac variant offering subglottic secretion drainage) work to reduce the risk of bloodstream and respiratory tract infections by minimizing biofilm formation. Beyond its BIP portfolio, the company offers a diverse array of other products, including Hydrocyn aqua advanced wound care for cleaning and debriding acute, chronic, and infected wounds, as well as general Bactiguard Wound Care items. It also provides a comprehensive selection of surgical sutures (natural absorbable, synthetic absorbable, non-absorbable, and specialty types), VigiMesh for hernia repair, and Hydrocyn aqua advanced disinfectant for sanitizing skin and surfaces. Additionally, Bactiguard supplies specialized orthopedic trauma implants featuring infection prevention technology under the ZNN Bactiguard brand, and the Aniocyn line of wound and skin care products for various pets. Bactiguard Holding AB (publ) was established in 2005 and maintains its headquarters in Tullinge, Sweden.
Show more...
CEO
Christine Lind
Employees
164
Country
Sweden
ISIN
SE0005878741
WKN
000A115EQ

Listings

0 Comments

Share your thoughts

FAQ

What is Bactiguard AB stock price today?
The current price of 5JE.F is €1.32 EUR — it has decreased by -0.75% in the past 24 hours. Watch Bactiguard AB stock price performance more closely on the chart.
What is Bactiguard AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Bactiguard AB stocks are traded under the ticker 5JE.F.
Is Bactiguard AB stock price growing?
5JE.F stock has risen by +5.18% compared to the previous week, the month change is a -3.3% fall, over the last year Bactiguard AB has showed a -39.73% decrease.
What is Bactiguard AB market cap?
Today Bactiguard AB has the market capitalization of 40.98M
When is the next Bactiguard AB earnings date?
Bactiguard AB is going to release the next earnings report on October 22, 2026.
What were Bactiguard AB earnings last quarter?
5JE.F earnings for the last quarter are -0.02 EUR per share, whereas the estimation was -0.03 EUR resulting in a +33.33% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Bactiguard AB revenue for the last year?
Bactiguard AB revenue for the last year amounts to 19.72M EUR.
What is Bactiguard AB net income for the last year?
5JE.F net income for the last year is -688,293.84 EUR.
How many employees does Bactiguard AB have?
As of September 04, 2026, the company has 164 employees.
In which sector is Bactiguard AB located?
Bactiguard AB operates in the Health & Wellness sector.
When did Bactiguard AB complete a stock split?
Bactiguard AB has not had any recent stock splits.
Where is Bactiguard AB headquartered?
Bactiguard AB is headquartered in Stockholm, Sweden.